Please use this identifier to cite or link to this item:
|Title:||Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2||Authors:||Narasimhan, K.
Bin Ahmad, N.R.
|Issue Date:||17-Jun-2011||Citation:||Narasimhan, K., Pillay, S., Bin Ahmad, N.R., Bikadi, Z., Hazai, E., Yan, L., Kolatkar, P.R., Pervushin, K., Jauch, R. (2011-06-17). Identification of a polyoxometalate inhibitor of the DNA binding activity of sox2. ACS Chemical Biology 6 (6) : 573-581. ScholarBank@NUS Repository. https://doi.org/10.1021/cb100432x||Abstract:||Aberrant expression of transcription factors is a frequent cause of disease, yet drugs that modulate transcription factor protein-DNA interactions are presently unavailable. To this end, the chemical tractability of the DNA binding domain of the stem cell inducer and oncogene Sox2 was explored in a high-throughput fluorescence anisotropy screen. The screening revealed a Dawson polyoxometalate (K 6[P 2Mo 18O 62]) as a direct and nanomolar inhibitor of the DNA binding activity of Sox2. The Dawson polyoxometalate (Dawson-POM) was found to be selective for Sox2 and related Sox-HMG family members when compared to unrelated paired and zinc finger DNA binding domains. [ 15N, 1H]-Transverse relaxation optimized spectroscopy (TROSY) experiments coupled with docking studies suggest an interaction site of the POM on the Sox2 surface that enabled the rationalization of its inhibitory activity. The unconventional molecular scaffold of the Dawson-POM and its inhibitory mode provides strategies for the development of drugs that modulate transcription factors. © 2011 American Chemical Society.||Source Title:||ACS Chemical Biology||URI:||http://scholarbank.nus.edu.sg/handle/10635/115436||ISSN:||15548929||DOI:||10.1021/cb100432x|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Sep 23, 2022
WEB OF SCIENCETM
checked on Sep 15, 2022
checked on Sep 22, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.